Clinical Trial Update: UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Systemic Lupus Erythematosus [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial from Zhejiang University evaluating UCAR T-cell therapy targeting CD19/BCMA in patients with relapsed/refractory systemic lupus …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• UCAR T-cell Therapy

Snippet

Sponsor: Zhejiang University | Conditions: Systemic Lupus Erythematosus | EARLY_Phase 1 | Status: RECRUITING